BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28573218)

  • 1. EFFECT OF THAI SARAPHI FLOWER EXTRACTS ON WT1 AND BCR/ABL PROTEIN EXPRESSION IN LEUKEMIC CELL LINES.
    Sangkaruk R; Rungrojsakul M; Tima S; Anuchapreeda S
    Afr J Tradit Complement Altern Med; 2017; 14(2):16-24. PubMed ID: 28573218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of mammea E/BB from Mammea siamensis seed extract on Wilms' tumour 1 protein expression in a K562 leukaemic cell line.
    Rungrojsakul M; Saiai A; Ampasavate C; Anuchapreeda S; Okonogi S
    Nat Prod Res; 2016; 30(4):443-7. PubMed ID: 25738951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms' Tumor 1 expression in K562 cells.
    Rungrojsakul M; Katekunlaphan T; Saiai A; Ampasavate C; Okonogi S; Sweeney CA; Anuchapreeda S
    BMC Complement Altern Med; 2016 May; 16():130. PubMed ID: 27193767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and chemical characterization of Cynara cardunculus L. extract and its potential use as co-adjuvant therapy of chronic myeloid leukemia.
    Russo A; Perri M; Cione E; Di Gioia ML; Nardi M; Cristina Caroleo M
    J Ethnopharmacol; 2017 Apr; 202():184-191. PubMed ID: 28323047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and inhibition of P-glycoprotein by selected medicinal plants from Thailand.
    Noysang C; Mahringer A; Zeino M; Saeed M; Luanratana O; Fricker G; Bauer R; Efferth T
    J Ethnopharmacol; 2014 Aug; 155(1):633-41. PubMed ID: 24929106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
    Anuchapreeda S; Tima S; Duangrat C; Limtrakul P
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):585-94. PubMed ID: 18034345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
    Montano G; Vidovic K; Palladino C; Cesaro E; Sodaro G; Quintarelli C; De Angelis B; Errichiello S; Pane F; Izzo P; Grosso M; Gullberg U; Costanzo P
    Oncotarget; 2015 Sep; 6(29):28223-37. PubMed ID: 26320177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo].
    Wu D; Lin MF; Zhao XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):373-8. PubMed ID: 15972123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
    Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
    Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial potential of compounds isolated from Mammea siamensis T. Anders. flowers: in vitro and molecular docking studies.
    Chaniad P; Chukaew A; Payaka A; Phuwajaroanpong A; Techarang T; Plirat W; Punsawad C
    BMC Complement Med Ther; 2022 Oct; 22(1):266. PubMed ID: 36224571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time quantitative PCR detection of WT1 and M-BCR-ABL expressions in chronic myeloid leukemia.
    Szántó A; Pap Z; Dénes L; Benedek Lázár E; Horváth A; Tunyogi AB; Baróti BÁ; Pávai Z
    Rom J Morphol Embryol; 2015; 56(2 Suppl):703-7. PubMed ID: 26429162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxic activity of Sa-Tri-Lhung-Klod remedy and its herbal ingredients on ovarian and cervical carcinoma cell lines.
    Inprasit J; Ruangnoo S; Itharat A
    J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S149-55. PubMed ID: 25518307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
    Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ
    Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of Qingdai compound on expression of bcr/abl and JWA in K562 cells].
    Dai HP; Shen Q; Zhou JW; Tang WY; Zhu GR; Xia W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):809-11. PubMed ID: 16277847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein.
    Karimiani EG; Marriage F; Merritt AJ; Burthem J; Byers RJ; Day PJ
    Exp Hematol; 2014 Mar; 42(3):183-191.e5. PubMed ID: 24269846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.
    Svensson E; Vidovic K; Lassen C; Richter J; Olofsson T; Fioretos T; Gullberg U
    Leukemia; 2007 Dec; 21(12):2485-94. PubMed ID: 17728783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
    Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Turmeric Bisdemethoxycurcumin Suppresses Wilms' Tumor 1 and CD34 Protein Expressions in KG-1a Leukemic Stem Cells.
    Panyajai P; Tima S; Chiampanichayakul S; Anuchapreeda S
    Nutr Cancer; 2019; 71(7):1189-1200. PubMed ID: 30955364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
    Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.